Literature DB >> 16472740

Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.

Xueyong Zhu1, Tobin J Dickerson, Claude J Rogers, Gunnar F Kaufmann, Jenny M Mee, Kathleen M McKenzie, Kim D Janda, Ian A Wilson.   

Abstract

Antibody 7A1 hydrolyzes cocaine to produce nonpsychoactive metabolites ecgonine methyl ester and benzoic acid. Crystal structures of 7A1 Fab' and six complexes with substrate cocaine, the transition state analog, products ecgonine methyl ester and benzoic acid together and individually, as well as heptaethylene glycol have been analyzed at 1.5-2.3 angstroms resolution. Here, we present snapshots of the complete cycle of the cocaine hydrolytic reaction at atomic resolution. Significant structural rearrangements occur along the reaction pathway, but they are generally limited to the binding site, including the ligands themselves. Several interacting side chains either change their rotamers or alter their mobility to accommodate the different reaction steps. CDR loop movements (up to 2.3 angstroms) and substantial side chain rearrangements (up to 9 angstroms) alter the shape and size (approximately 320-500 angstroms3) of the antibody active site from "open" to "closed" to "open" for the substrate, transition state, and product states, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472740     DOI: 10.1016/j.str.2005.10.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  14 in total

Review 1.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Unexpected acetylcholinesterase activity of cocaine esterases.

Authors:  Claude J Rogers; Lisa M Eubanks; Tobin J Dickerson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2006-12-06       Impact factor: 15.419

3.  Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.

Authors:  Yongmei Pan; Daquan Gao; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2008-03-15       Impact factor: 15.419

4.  Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.

Authors:  Kemin Tan; Min Zhou; Angela J Ahrendt; Norma E C Duke; Nassif Tabaja; William J Ball; Terence L Kirley; Andrew B Norman; Andrzej Joachimiak; Marianne Schiffer; Rosemarie Wilton; P Raj Pokkuluri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-11-05       Impact factor: 1.056

5.  A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.

Authors:  Michael Lape; Stefan Paula; William J Ball
Journal:  Eur J Med Chem       Date:  2010-02-06       Impact factor: 6.514

6.  Crystal structures of a quorum-quenching antibody.

Authors:  Erik W Debler; Gunnar F Kaufmann; Robert N Kirchdoerfer; Jenny M Mee; Kim D Janda; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

7.  Identification and characterization of single chain anti-cocaine catalytic antibodies.

Authors:  Kathleen M McKenzie; Jenny M Mee; Claude J Rogers; Mark S Hixon; Gunnar F Kaufmann; Kim D Janda
Journal:  J Mol Biol       Date:  2006-11-03       Impact factor: 5.469

8.  Computational design of protein-small molecule interfaces.

Authors:  Brittany Allison; Steven Combs; Sam DeLuca; Gordon Lemmon; Laura Mizoue; Jens Meiler
Journal:  J Struct Biol       Date:  2013-08-17       Impact factor: 2.867

9.  Conformational isomerism can limit antibody catalysis.

Authors:  Erik W Debler; Roger Müller; Donald Hilvert; Ian A Wilson
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

10.  Antibody-catalyzed anaerobic destruction of methamphetamine.

Authors:  Yang Xu; Mark S Hixon; Noboru Yamamoto; Laura A McAllister; Anita D Wentworth; Paul Wentworth; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.